PALLD-NAA15 Fusion FISH Probe
The PALLD-NAA15 Fusion FISH Probe is used to confirm a fusion of the PALLD and NAA15 genes. The fusion of the PALLD and NAA15 genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| PALLD-NAA15-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-RERE | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-REOR | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-REGO | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-REGR | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-OROR | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-GORE | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-GROR | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| PALLD-NAA15-20-AQAQ | 20 (40 μL) | 200 μL |
|
PALLD Gene Summary
This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
Gene Name: Palladin, Cytoskeletal Associated Protein
Chromosome: CHR4: 169418216 -169849608
Locus: 4q32.3
NAA15 Gene Summary
N-alpha-acetylation is among the most common post-translational protein modifications in eukaryotic cells. This process involves the transfer of an acetyl group from acetyl-coenzyme A to the alpha-amino group on a nascent polypeptide and is essential for normal cell function. This gene encodes the auxillary subunit of the N-terminal acetyltransferase A (NatA) complex. [provided by RefSeq, Jan 2017]
Gene Name: N(alpha)-acetyltransferase 15, NatA Auxiliary Subunit
Chromosome: CHR4: 140222675 -140311935
Locus: 4q31.1
Gene Diseases
The PALLD NAA15 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|